CERC-301
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for CERC-301, covering 2017-09-28 to 2017-12-21. Get the full timeline:
Most recent: Clinical Trial Update: A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment [Phase 2]